Nils David Gustafsson

Title: Nils David Gustafsson: Innovator in Pharmaceutical Preparations

Introduction

Nils David Gustafsson is a notable inventor based in Kullavik, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptide derivatives and thrombin inhibitors. With a total of 6 patents to his name, Gustafsson's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents, one focuses on peptide derivatives, specifically a pharmaceutical preparation containing an effective amount of acetylsalicylic acid and a compound of Formula I.A—A—NH—(CH)—B. Another significant invention relates to new competitive tripeptide inhibitors of trypsin-like serine proteases. This invention includes their synthesis, pharmaceutical compositions containing the compounds as active ingredients, and their use as thrombin inhibitors, anticoagulants, and anti-inflammatory agents for the prophylaxis and treatment of related diseases.

Career Highlights

Throughout his career, Nils David Gustafsson has worked with prominent companies in the pharmaceutical industry, including Astra Aktiebolag and Astra AB. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Gustafsson has collaborated with several talented individuals in his field, including Karl Thomas Antonsson and Ruth Elvy Bylund. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Nils David Gustafsson is a distinguished inventor whose work in pharmaceuticals has led to important advancements in medical treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.